Laurus Labs Limited
LAURUSLABS
Κατάταξη σε μετοχές
#1741
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Τιμή μετοχής
$22.83
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$12.34B
Αλλαγή (1 ημέρα)
0.51%
Αλλαγή (1 έτος)
117.95%
Χώρα
IN
Εμπόριο Laurus Labs Limited (LAURUSLABS)
Κατηγορία
Healthcare
Δείκτης P/S για Laurus Labs Limited (LAURUSLABS)
Δείκτης P/S στις October 2026 TTM: 15.12
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Laurus Labs Limited, ο τρέχων δείκτης P/S (TTM) είναι 15.12. Στο τέλος του 2024, ο δείκτης ήταν 4.35.
Ιστορικό P/S για την Laurus Labs Limited από 2013 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 15.12 | 159.78% |
| 2025 | 5.82 | 33.90% |
| 2024 | 4.35 | 66.65% |
| 2023 | 2.61 | -59.76% |
| 2022 | 6.48 | 57.81% |
| 2021 | 4.11 | 226.89% |
| 2020 | 1.26 | -33.15% |
| 2019 | 1.88 | -30.33% |
| 2018 | 2.70 | 7.66% |
| 2017 | 2.50 | 13.66% |
| 2016 | 2.20 | -2.38% |
| 2015 | 2.26 | -11.20% |
| 2014 | 2.54 | -53.23% |
| 2013 | 5.44 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -53.32% |
IN
|
